Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma-Reference-Cited by-同舟云学术

Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma

Published:2015-06 Issue:3 Volume:25 Page:239-245
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Ferrucci Pier F.,Minchella Ida,Mosconi Massimo,Gandini Sara,Verrecchia Francesco,Cocorocchio Emilia,Passoni Claudia,Pari Chiara,Testori Alessandro,Coco Paola,Munzone Elisabetta

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference39 articles.

1. Systematic review of medical treatment in melanoma: current status and future prospects.;Garbe;Oncologist,2011

2. Angiogenesis, lymphangiogenesis, and melanoma metastasis.;Streit;Oncogene,2003

3. Challenging resistance mechanisms to therapies for metastatic melanoma.;Tentori;Trends Pharmacol Sci,2013

4. . Improved survival with vemurafenib in melanoma with BRAF V600E mutation.;Chapman;N Engl J Med,2011

5. . Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.;Flaherty;N Engl J Med,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives;Life Sciences;2024-05

2. Advances in targeted therapy and immunotherapy for melanoma (Review);Experimental and Therapeutic Medicine;2023-07-13

3. Efficacy and safety of bevacizumab in patients with malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies;Frontiers in Pharmacology;2023-07-13

4. The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment;Frontiers in Immunology;2022-02-23

5. Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma;Cancers;2022-01-06